Examining the impact of several factors including COVID ‐19 on thyroid fine‐needle aspiration biopsy
Diagnostic Cytopathology · 2024
DOI: 10.1002/dc.25239 ↗At a glance
Beobachtungsstudie in Diagnostic Cytopathology, 2024. Written by Muzaffer Serdar Deniz and 1 co-authors. Institution: Department of Endocrinology, Faculty of Medicine, Education and Research Hospital, Karabük University, Karabük, Turkey. Major MEDLINE topics: Thyroid Nodule, Thyroid Neoplasms, COVID-19. Cited 4 times so far (Crossref); 34 references.
Abstract (original language)
Objective
The study explores various factors, including coronavirus disease 2019 (COVID‐19) history and vaccination status, that influence the classification value of ultrasonography‐guided thyroid fine needle aspiration biopsy (TFNAB) by comparing non‐diagnostic (Bethesda‐I) and diagnostic (Bethesda II–VI) results.
Methods
We conducted a retrospective observational study in a high‐volume tertiary care center involving patients who underwent TFNAB from November 2022 to April 2023. The study retrospectively analyzed the cytopathology of 482 thyroid nodules. Patients were categorized into non‐diagnostic ( n = 136) and Diagnostic groups ( n = 346) based on TFNAB. A comprehensive set of parameters was examined, including demographic, anthropometric and clinical data, thyroid ultrasonography findings, COVID‐19 history and immunization status.
Results
The mean age was 55.1 ± 12.1 years in the non‐diagnostic group and 53.5 ± 13 years in the Diagnostic group ( p = .223). 75.7% ( n = 103) of the non‐Diagnostic group and 82.9% ( n = 287) of the Diagnostic group were male ( p = .070). The mean nodule longitudinal diameter of the Diagnostic group was significantly higher than that of the non‐diagnostic group ( p = .015). The TIRADS score of the nodules showed a statistical difference between the groups ( p = .048). The groups had no significant differences regarding other ultrasonographic parameters and COVID‐19‐related variables.
Conclusion
It can be assumed that when the longitudinal diameter of the thyroid nodule is small and in TIRADS categories other than the TIRADS3 category, TFNAB is less likely to be diagnostic. However, future research may be needed to confirm these findings and uncover any long‐term effects of COVID‐19 or vaccines on thyroid nodule diagnostics.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Endocrinology, Faculty of Medicine, Education and Research Hospital, Karabük University, Karabük, Turkey.
- Department of Internal Medicine, Faculty of Medicine, Education and Research Hospital, Karabük University, Karabük, Turkey.
ORCID profiles: Muzaffer Serdar Deniz, Merve Dindar
Cite
APA
Deniz, M. S., & Dindar, M. (2024). Examining the impact of several factors including COVID ‐19 on thyroid fine‐needle aspiration biopsy. Diagnostic Cytopathology. https://doi.org/10.1002/dc.25239
Vancouver
Deniz MS, Dindar M. Examining the impact of several factors including COVID ‐19 on thyroid fine‐needle aspiration biopsy. Diagnostic Cytopathology. 2024. doi:10.1002/dc.25239
BibTeX
@article{Deniz2024,
author = {Deniz, Muzaffer Serdar and Dindar, Merve},
title = {Examining the impact of several factors including COVID ‐19 on thyroid fine‐needle aspiration biopsy},
journal = {Diagnostic Cytopathology},
year = {2024},
doi = {10.1002/dc.25239}
}
EUVIMED